Patient-Level Omics Data Analysis Identifies Gene-Specific Survival Associations for a PD-1/PD-L1 Network in Pleural Mesothelioma
Immune checkpoint blockade targeting <i>PDCD1</i> (PD-1) or <i>CD274</i> (PD-L1) has demonstrated efficacy and interest across multiple cancers. However, the exact determinants of the response and cancer-specific molecular features remain unclear. A recent pan-cancer study id...
Main Authors: | Geraldine M. O’Connor, Emyr Y. Bakker |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | BioMedInformatics |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-7426/2/4/37 |
Similar Items
-
Molecular Mechanisms of PD-1 and PD-L1 Activity on a Pan-Cancer Basis: A Bioinformatic Exploratory Study
by: Siddarth Kannan, et al.
Published: (2021-05-01) -
Circulating Levels of PD-L1 in Mesothelioma Patients from the NIBIT-MESO-1 Study: Correlation with Survival
by: Carla Chiarucci, et al.
Published: (2020-02-01) -
PD-L1 expression complements CALGB prognostic scoring system in malignant pleural mesothelioma
by: Alejandro Avilés-Salas, et al.
Published: (2023-12-01) -
Anti-PD1 does not improve pyroptosis induced by γδ T cells but promotes tumor regression in a pleural mesothelioma mouse model
by: Ka Sin Lui, et al.
Published: (2023-11-01) -
Immunotherapeutic Approaches in Malignant Pleural Mesothelioma
by: Rita Terenziani, et al.
Published: (2021-06-01)